Targeting &gamma;-secretase in breast cancer

Código QR

Targeting &gamma;-secretase in breast cancer

Jianxun Han,1 Qiang Shen21Department of Chemical Engineering and Applied Chemistry, University of Toronto, 2Campbell Family Institute for Breast Cancer Research, Princess Margaret Hospital, University Health Network, Toronto, Ontario, CanadaAbstract: &gamma;-secretase complexes are multisubu...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Han J, Shen Q
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2012
Materias:	Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Acceso en línea:	https://doaj.org/article/b77bf96fafb04026b62e089787da0c0e
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Emerging targeted combinations in the management of breast cancer
por: Lee RJ, et al.
Publicado: (2013)

Inhibiting breast cancer by targeting the thromboxane A2 pathway
por: Haitao Li, et al.
Publicado: (2017)

New approaches in the management of advanced breast cancer &ndash; role of combination treatment with liposomal doxorubicin
por: Iain RJ Macpherson, et al.
Publicado: (2009)

Revisiting the IGF-1R as a breast cancer target
por: Roudy Chiminch Ekyalongo, et al.
Publicado: (2017)

Molecular stratification of early breast cancer identifies drug targets to drive stratified medicine
por: Jane Bayani, et al.
Publicado: (2017)

Synergistic targeting of BRCA1 mutated breast cancers with PARP and CDK2 inhibition
por: Diar Aziz, et al.
Publicado: (2021)

Targeting nucleotide metabolism enhances the efficacy of anthracyclines and anti-metabolites in triple-negative breast cancer
por: Craig Davison, et al.
Publicado: (2021)

Inherited predisposition to breast cancer in the Carolina Breast Cancer Study
por: Tom Walsh, et al.
Publicado: (2021)

Does Veritas&reg; play a role in breast reconstruction? a case report
por: De Vita F, et al.
Publicado: (2011)

Identification of genes involved in breast cancer and breast cancer stem cells
por: Apostolou P, et al.
Publicado: (2015)

Acetylation of ELF5 suppresses breast cancer progression by promoting its degradation and targeting CCND1
por: Xiahui Li, et al.
Publicado: (2021)

Dormancy in breast cancer
por: Banys M, et al.
Publicado: (2012)

Identification, validation, and targeting of the mutant p53-PARP-MCM chromatin axis in triple negative breast cancer
por: Wei-Gang Qiu, et al.
Publicado: (2017)

CTEN Inhibits Tumor Angiogenesis and Growth by Targeting VEGFA Through Down-Regulation of β-Catenin in Breast Cancer
por: Xiangdong Lu PhD, et al.
Publicado: (2021)

The contribution of pathogenic variants in breast cancer susceptibility genes to familial breast cancer risk
por: Thomas P. Slavin, et al.
Publicado: (2017)

Bispecific antibody targeting TROP2xCD3 suppresses tumor growth of triple negative breast cancer
por: Huicheng Liu, et al.
Publicado: (2021)

Tumor-associated autoantibodies from mouse breast cancer models are found in serum of breast cancer patients
por: Sasha E. Stanton, et al.
Publicado: (2021)

An alternative model for (breast) cancer predisposition
por: Erik Teugels, et al.
Publicado: (2017)

Current strategies for the prevention of breast cancer
por: Advani P, et al.
Publicado: (2014)

Optical imaging for breast cancer prescreening
por: Godavarty A, et al.
Publicado: (2015)

Targeting the duality of cancer
por: Jack L. Arbiser, et al.
Publicado: (2017)

Can population breast screening programs be leveraged to reduce the burden of breast cancer?
por: Nehmat Houssami
Publicado: (2021)

Establishment and characterization of immortalized human breast cancer cell lines from breast cancer patient-derived xenografts (PDX)
por: Yongxian Zhuang, et al.
Publicado: (2021)

Automated and rapid detection of cancer in suspicious axillary lymph nodes in patients with breast cancer
por: Juanjuan Li, et al.
Publicado: (2021)

Dynamic contrast-enhanced breast MRI features correlate with invasive breast cancer angiogenesis
por: Jennifer Xiao, et al.
Publicado: (2021)

Bones, breasts, and bisphosphonates: rationale for the use of zoledronic acid in advanced and early breast cancer
por: Allan Lipton
Publicado: (2011)

Combined 2-deoxy glucose and metformin improves therapeutic efficacy of sodium-iodide symporter-mediated targeted radioiodine therapy in breast cancer cells
por: Chatterjee S, et al.
Publicado: (2015)

A triple negative breast cancer: what it is not!
por: Katakkar SB
Publicado: (2012)

Breast cancer in Brazil: epidemiology and treatment challenges
por: Cecilio AP, et al.
Publicado: (2015)

Tamoxifen for women at high risk of breast cancer
por: Nazarali SA, et al.
Publicado: (2014)

Triple negative breast cancer: an Indian perspective
por: Akhtar M, et al.
Publicado: (2015)

Taxanes in the elderly patient with metastatic breast cancer
por: Yardley DA
Publicado: (2015)

Breast cancers are rare diseases—and must be treated as such
por: John M. S. Bartlett, et al.
Publicado: (2017)

Benefits of multidisciplinary teamwork in the management of breast cancer
por: Taylor C, et al.
Publicado: (2013)

Immunotherapy in breast cancer: A clinician's perspective
por: Sibapriya Chaudhuri, et al.
Publicado: (2021)

Multidrug-resistant breast cancer: current perspectives
por: Martin HL, et al.
Publicado: (2014)

Recent advances in the development of breast cancer vaccines
por: Milani A, et al.
Publicado: (2014)

Cancer biomarker HER-2/neu in breast cancer in Indian women
por: Singhai R, et al.
Publicado: (2011)

Evaluation of overall survival and barriers to surgery for patients with breast cancer treated without surgery: a National Cancer Database analysis
por: D. Boyce-Fappiano, et al.
Publicado: (2021)

Implications for breast cancer dormancy in other areas of medicine
por: Rameshwar P
Publicado: (2012)